MedTrace Logo

FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum

NCT00077233 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 238

Last updated 2018-05-16

No results posted yet for this study

Summary

This is a randomized phase II study trial that has served as a screening trial to test the increased efficacy of chemotherapy + cetuximab versus chemotherapy alone among patients with untreated, advanced or metastatic colon cancer regardless of tumor status with respect to EGFR.

Conditions

Interventions

DRUG

cetuximab

IV

DRUG

5-FU

IV

DRUG

irinotecan

IV

DRUG

leucovorin

IV

DRUG

oxaliplatin

IV

Sponsors & Collaborators

Principal Investigators

  • Alan Venook, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2006-12-31
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00077233 on ClinicalTrials.gov